Jaguar Animal Health Inc (JAGX) Stock Analysis

Jaguar Animal Health Inc (JAGX) is a publicly traded company in the HEALTHCARE sector. It trades at $3.22, carries a market capitalization of $2.15M. This page summarizes the public market data, fundamentals, and frequently asked questions for JAGX, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $3.22
• Market Cap: $2.15M
• EPS: $-695.50
• 52-Week High: $144.90
• 52-Week Low: $2.53

Market Sentiment

Jaguar Animal Health Inc currently has a Bullish sentiment score of 0.44.

About Jaguar Animal Health Inc

Jaguar Animal Health, Inc. (JAGX) is a commercial-stage biopharmaceutical company headquartered in San Francisco, focused on developing innovative prescription therapies for both human and animal health, with a primary emphasis on chronic gastrointestinal disorders and debilitating diarrhea. Utilizing proprietary technologies rooted in extensive research of the gastrointestinal microbiome, Jaguar Health is committed to delivering effective and sustainable healthcare solutions that enhance the...

GNG Research Analysis

GNG Research scores Jaguar Animal Health Inc (JAGX) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for JAGX.

Frequently Asked Questions

Does JAGX pay dividends?

Jaguar Animal Health Inc (JAGX) does not currently pay a regular dividend.

What is JAGX's market cap?

Jaguar Animal Health Inc (JAGX) has a market capitalization of $2.15M with a current stock price of $3.22.